957120-32-0

Basic information

• Product Name: 5-fluoro-2-methoxy-3-pyridineboronic acid
• Synonyms: 5-fluoro-2-methoxy-3-pyridineboronic acid;5-Fluoro-2-methoxypyridin-3-ylboronic acid;3-Borono-5-fluoro-2-methoxypyridine;Boronicacid,B-(5-fluoro-2-methoxy-3-pyridinyl);5-Fluoro-2-methoxypyridine-3-boronicacid96%
• CAS NO: 957120-32-0
• Molecular Formula: C₆H₇BFNO₃
• Molecular Weight: 170.94
• Product Categories: blocks;BoronicAcids;API intermediates
• Mol File: 957120-32-0.mol

Chemical Properties

• Boiling Point: 327.6 °C at 760 mmHg
• Flash Point: 151.9 °C
• Appearance: /
• Density: 1.34
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-fluoro-2-methoxy-3-pyridineboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-fluoro-2-methoxy-3-pyridineboronic acid(957120-32-0)
• EPA Substance Registry System: 5-fluoro-2-methoxy-3-pyridineboronic acid(957120-32-0)

Safety Data

• Hazardous Substances Data: 957120-32-0(Hazardous Substances Data)

Usage

Uses

5-Fluoro-2-methoxypyridine-3-boronic acid

InChI:InChI=1S/C6H7BFNO3/c1-12-6-5(7(10)11)2-4(8)3-9-6/h2-3,10-11H,1H3

Upstream product

• 884494-81-9 3-bromo-5-fluoro-2-methoxypyridine 
• 5419-55-6 Triisopropyl borate 

Downstream Products

• 1206772-42-0 N-[4-[(E)-2-[3-tert-butyl-5-(5-fluoro-2-oxo-1H-pyridin-3-yl)-2-methoxyphenyl]vinyl]phenyl]methanesulfonamide 
• 1256489-00-5 C₂₇H₂₈FN₃O₅S 
• 1257832-02-2 4-tert-butyl-2-(5-fluoro-2-methoxy-3-pyridyl)aniline 
• 1257830-20-8 N-[4-[6-tert-butyl-8-(5-fluoro-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide 
• 1485748-91-1 N-[4-[6-tert-butyl-8-(5-fluoro-2-methoxy-3-pyridyl)-5-methoxy-3-quinolyl]phenyl]methanesulfonamide 

Relevant articles and documents

IMIDAZO [1,2-B] PYRIDAZINE AND IMIDAZO [4,5-B] PYRIDINE DERIVATIVES AS JAK INHIBITORS

New imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors

New imidazo[1,2-b]pyridazine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).